Cargando…
Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
Immune checkpoint inhibitors (ICI) are treatments for several cancer types. Pathogenesis of ICI-induced colitis is not yet clearly explained as it can be disguised as another form such as inflammatory bowel disease or IBD. Recent studies revealed that ICI-induced colitis is a unique form of colitis...
Autores principales: | Alorfi, Nasser M, Alourfi, Mansour Marzouq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362776/ https://www.ncbi.nlm.nih.gov/pubmed/35957978 http://dx.doi.org/10.2147/BTT.S367675 |
Ejemplares similares
-
Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
por: Perez Del Nogal, Genesis, et al.
Publicado: (2022) -
Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
por: Zhang, Eva, et al.
Publicado: (2021) -
Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis
por: Kaneoka, Ayaka, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018) -
A case of refractory immune checkpoint inhibitor‐induced colitis with Clostridioides difficile infection
por: Okura, Yukito, et al.
Publicado: (2022)